Abstract:
PURPOSE: A composition containing Thalictrum aquilegifolium extract is provided to suppress bone resorption and to prevent and treat bone diseases. CONSTITUTION: A pharmaceutical composition for preventing and treating bone diseases contains Thalictrum aquilegifolium extract as an active ingredient. The bone diseases are caused by metastasis and include osteoporosis, osteomalacis, rachitis, osteitis fibrosa, aplastic bone disease, or metabolic bone disease. A food composition for treating and relieving bond diseases contains the extract as an active ingredient.